Trametes versicolor — named for its turkey tail-like concentric bands of color — grows on dead hardwood logs throughout temperate forests worldwide. It is one of the most abundant and widely distributed medicinal mushrooms. It is also the most rigorously studied.
PSK and PSP: The Clinically Validated Compounds
Turkey Tail's two most researched compounds are protein-bound polysaccharides: PSK (polysaccharide-K, also called Krestin) and PSP (polysaccharide-peptide). PSK has been used as an approved cancer adjunct therapy in Japan since 1977. It is covered by national health insurance and is standard of care in combination with conventional cancer treatment in Japan and several other Asian countries.
The Cancer Research: Serious Evidence
Colorectal Cancer
The clinical evidence for PSK in colorectal cancer is substantial. A 1994 meta-analysis of PSK in colorectal cancer patients enrolled over 8,000 patients and found statistically significant improvements in 5-year survival rates across multiple cancer stages. Effect sizes were clinically meaningful — particularly in Stage II and III patients where PSK adjunct therapy resulted in 5-year survival rates 5-10 percentage points higher than chemotherapy alone.
Breast Cancer
A landmark 2012 study published in ISRN Oncology was the first FDA-approved Phase I clinical trial examining Turkey Tail in breast cancer patients. The study, conducted by researchers at the University of Minnesota and Bastyr University, found that Turkey Tail significantly restored immune function in breast cancer patients who had received radiation therapy — including NK cell activity, CD8+ T-cell counts, and B-cell populations. These are the precise immune parameters most suppressed by conventional cancer treatment.
Gastric Cancer
Multiple Japanese clinical trials have found PSK to significantly improve 5-year survival in gastric cancer patients when used alongside surgery and chemotherapy. A 2002 study in the British Journal of Cancer found that PSK reduced the rate of repeat cancer occurrence following surgical resection.
Mechanism: Training the Immune System
Turkey Tail's immune effects operate through several mechanisms. PSK binds to Dectin-1, TLR-2, and other pattern recognition receptors on immune cells, initiating a cascade that activates macrophages, NK cells, dendritic cells, and T-lymphocytes. Critically, PSK has been shown to reduce immune suppression caused by tumors — many cancers secrete immunosuppressive cytokines that essentially hide them from immune surveillance. PSK counteracts this immune evasion.
My oncologist mentioned PSK after I asked about integrative options during my breast cancer treatment. She told me the FDA trial data was legitimate and that the immune restoration findings were consistent with what she'd observed clinically. I added Turkey Tail throughout my treatment. My immune labs post-radiation were significantly better than she expected. — Turkey Tail consumer, 44, Seattle
Prebiotic and Gut Microbiome Effects
A 2014 study in PLOS ONE found that Turkey Tail polysaccharides act as prebiotics — selectively feeding beneficial bacterial populations including Bifidobacterium and Lactobacillus while reducing opportunistic pathogens. Given the bidirectional relationship between gut microbiome health and immune function, this prebiotic effect may contribute meaningfully to Turkey Tail's systemic immune benefits.
The Quality Distinction
As with other medicinal mushrooms, the gap between high-quality and low-quality Turkey Tail products is wide. Fruiting body extraction with verified beta-glucan content is the standard that mirrors what was used in clinical trials. Mycelium-on-grain products with unverified polysaccharide content are unlikely to deliver the effects documented in research.